326 related articles for article (PubMed ID: 1709847)
21. Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats.
Giustina A; Misitano V; Voltz D; Piering A; Wehrenberg WB
Endocr Res; 1995 Nov; 21(4):719-32. PubMed ID: 8582323
[TBL] [Abstract][Full Text] [Related]
22. [Effect of pre-treatment with pyridostigmine on the stimulation of growth hormone by clonidine and GRF].
Farello G; De Simone M; Gentile T; de Matteis F
Minerva Pediatr; 1991 Oct; 43(10):617-20. PubMed ID: 1758382
[TBL] [Abstract][Full Text] [Related]
23. The late growth hormone rise induced by oral glucose is enhanced by cholinergic stimulation with pyridostigmine in normal subjects.
Valcavi R; Zini M; Davoli S; Portioli I
Clin Endocrinol (Oxf); 1992 Oct; 37(4):360-4. PubMed ID: 1483293
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone response to overnight growth hormone-releasing hormone infusion and oral pyridostigmine in children with short stature.
Ross RJ; Savage MO; Kirk JM; Besser GM
Acta Paediatr Scand Suppl; 1989; 349():114-6; discussion 123-4. PubMed ID: 2501967
[TBL] [Abstract][Full Text] [Related]
25. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
[TBL] [Abstract][Full Text] [Related]
26. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
Jaffe CA; DeMott-Friberg R; Barkan AL
J Clin Invest; 1996 Feb; 97(4):934-40. PubMed ID: 8613546
[TBL] [Abstract][Full Text] [Related]
27. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
Ghigo E; Bellone J; Aimaretti G; Bellone S; Loche S; Cappa M; Bartolotta E; Dammacco F; Camanni F
J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
Ghigo E; Mazza E; Imperiale E; Rizzi G; Benso L; Müller EE; Camanni F; Massara F
J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
[TBL] [Abstract][Full Text] [Related]
29. The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
Spoudeas HA; Matthews DR; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 1992 Aug; 75(2):453-8. PubMed ID: 1353504
[TBL] [Abstract][Full Text] [Related]
30. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats.
Arce V; García Barros M; Vara E; Lima L; Tresguerres JA; Devesa J
Neuroendocrinology; 1995 May; 61(5):552-8. PubMed ID: 7617133
[TBL] [Abstract][Full Text] [Related]
31. Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients.
Borges MH; Castro RC; Kater CE; Lengyel AM
Braz J Med Biol Res; 1993 Nov; 26(11):1191-200. PubMed ID: 7907904
[TBL] [Abstract][Full Text] [Related]
32. Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children.
Ghigo E; Goffi S; Mazza E; Imperiale E; Arvat E; Bellone J; Procopio M; Müller EE; Camanni F
J Endocrinol Invest; 1989 Feb; 12(2):99-101. PubMed ID: 2754188
[TBL] [Abstract][Full Text] [Related]
33. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
[TBL] [Abstract][Full Text] [Related]
34. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
Beccaria L; Marziani E; Manzoni P; Arvat E; Valetto MR; Gianotti L; Ghigo E; Chiumello G
Dement Geriatr Cogn Disord; 1998; 9(2):78-81. PubMed ID: 9524798
[TBL] [Abstract][Full Text] [Related]
35. Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology.
Dammacco F; Boghen MF; Camanni F; Cappa M; Ferrari C; Ghigo E; Giordano G; Loche S; Minuto F; Mucci M
J Clin Endocrinol Metab; 1993 Jul; 77(1):68-72. PubMed ID: 8325962
[TBL] [Abstract][Full Text] [Related]
36. Cholinergic modulation of growth hormone-releasing hormone effects on growth hormone secretion in dementia.
Murialdo G; Zerbi F; Filippi U; Tosca P; Fonzi S; Di Paolo E; Costelli P; Porro S; Polleri A; Savoldi F
Neuropsychobiology; 1990-1991; 24(3):129-34. PubMed ID: 1983729
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
[TBL] [Abstract][Full Text] [Related]
38. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
[TBL] [Abstract][Full Text] [Related]
39. The role of the cholinergic pathway in growth hormone feedback.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
